Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

Stopping unnecessary cancer screenings can take over a decade after new guidelines are introduced, according to a review ...

Bhat: From a medication standpoint, there is still much to uncover regarding why treatments vary in effectiveness among ...

Bhat: I am an embedded clinical pharmacist and a part of the IBD medical home at Cleveland Clinic. In caring for patients ...

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

Bhat: A multidisciplinary approach is essential for managing the complexities of Crohn’s disease treatment, including setting expectations, handling prior authorizations, and addressing financial ...

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Bhat: With the rapidly advancing landscape of IBD treatments and the increasing complexities of the health care system, integrating clinical pharmacists into IBD care teams offers substantial benefits ...

Optometrists are well placed to notice signs of mental health issues in their patients and take action, according to a ...

Bhat: I appreciate the growing emphasis on incorporating patient quality-of-life assessments into clinical trials and practice, given the significant impact of this disease. Continuously integrating ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...